Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Lynn › NPI 1891232906
NP / PA

Uchendu, Stella

Uchendu, Stella was paid $482K by Medicaid between May 2019 and Dec 2024, across 7 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 34% of everything it billed.

33Billing provider infoUCHENDU, STELLA
LYNN, MA 01905
33aNPI1891232906assigned 01/26/2017
28Total paid$482K
24GClaims9,359
24DCodes billed7
24AFirst – last monthMay 2019 – Dec 2024
Compared with peers

Next to other Gerontology Nurse Practitioner providers in Massachusetts

Rank by total paid#1 of 12
Median peer was paid$16K
This provider vs. median29×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019572$29K
20202,627$143K
20212,743$159K
20222,754$120K
2023417$24K
2024incomplete246$7K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 34% 3,640 1,288 $164K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 33% 2,776 1,033 $157K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 24% 2,023 988 $114K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 8.1% 361 176 $39K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 1.1% 205 187 $5K
81025 <1% 263 84 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 91 55 $1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.